{"entity":{"type":"insider","cik":"0001950232","url":"/insider/0001950232","json_url":"/insider/0001950232.json","name":"Reardon Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":13,"first":"2023-03-28","last":"2026-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Reardon Andrew","source":"filing","n_filings":13,"first_seen":"2023-03-28","last_seen":"2026-08-04"}],"transactions":[{"id":6083898,"accession":"0002001011-26-000111","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0002001011-26-000111","line_url":"/filing/0002001011-26-000111","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":288.99018028,"price_display":"288.99","price_state":"stated","total_value":1444950.9014,"total_display":"1,444,950.90","total_whole":"1,444,951","shares_owned_after":43973.0,"shares_owned_after_display":"43,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-04","scope":"insider","n_lines":10},{"id":5925289,"accession":"0002001011-26-000108","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0002001011-26-000108","line_url":"/filing/0002001011-26-000108","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":313.27539704,"price_display":"313.28","price_state":"stated","total_value":1566376.9852,"total_display":"1,566,376.99","total_whole":"1,566,377","shares_owned_after":44895.0,"shares_owned_after_display":"44,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-06","scope":"insider","n_lines":8},{"id":5952115,"accession":"0002001011-26-000083","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0002001011-26-000083","line_url":"/filing/0002001011-26-000083","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":227.063114,"price_display":"227.06","price_state":"stated","total_value":1135315.57,"total_display":"1,135,315.57","total_whole":"1,135,316","shares_owned_after":43782.0,"shares_owned_after_display":"43,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider","n_lines":7},{"id":5853258,"accession":"0002001011-26-000046","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0002001011-26-000046","line_url":"/filing/0002001011-26-000046","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":231.31111944,"price_display":"231.31","price_state":"stated","total_value":1156555.5972,"total_display":"1,156,555.60","total_whole":"1,156,556","shares_owned_after":42182.0,"shares_owned_after_display":"42,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-04","scope":"insider","n_lines":7},{"id":5853246,"accession":"0002001011-26-000037","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0002001011-26-000037","line_url":"/filing/0002001011-26-000037","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":201.2448204,"price_display":"201.24","price_state":"stated","total_value":1006224.102,"total_display":"1,006,224.10","total_whole":"1,006,224","shares_owned_after":44620.0,"shares_owned_after_display":"44,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider","n_lines":6},{"id":6143317,"accession":"0002001011-26-000024","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0002001011-26-000024","line_url":"/filing/0002001011-26-000024","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":206.35405478,"price_display":"206.35","price_state":"stated","total_value":1031770.2739,"total_display":"1,031,770.27","total_whole":"1,031,770","shares_owned_after":38011.0,"shares_owned_after_display":"38,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":11},{"id":4607603,"accession":"0002001011-25-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-25-000048","line_url":"/filing/0002001011-25-000048#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001950232","owner_name":"Reardon Andrew","owner_display_name":"Reardon Andrew","owner_url":"/insider/0001950232","role":"Officer (CLO & Secretary)","role_mark":"O","role_mark_label":"Officer (CLO & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CLO & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":114.0843,"price_display":"114.08","price_state":"stated","total_value":57042.15,"total_display":"57,042.15","total_whole":"57,042","shares_owned_after":31903.0,"shares_owned_after_display":"31,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-23","filed_date":"2025-06-24","scope":"insider"}],"collapsed":true,"next_cursor":"2025-06-23|4607603","ledger_fault":false,"count":{"value":56,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":56,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":56},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Officer (CLO & Secretary)","n_filings":13,"first_seen":"2023-03-28","last_seen":"2026-08-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001950232","retrieved_at":"2026-08-26T11:07:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}